
Puma Biotechnology PBYI
€ 6.67
3.86%
Geschäftsbericht 2025
hinzugefügt 26.02.2026
Puma Biotechnology P/E 2011-2026 | PBYI
P/E Jährlich Puma Biotechnology
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.2 | 4.79 | 13.6 | 87.1 K | -4.24 | -6.77 | -4.15 | -9.02 | -8.37 | -3.7 | -5.6 | -44.6 | -65.2 | -7.09 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 87.1 K | -65.2 | 6.21 K |
P/E anderer Aktien in der Pharmaeinzelhändler
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
ACADIA Pharmaceuticals
ACAD
|
14.1 | $ 22.57 | 0.04 % | $ 3.74 B | ||
|
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M | ||
|
Adverum Biotechnologies
ADVM
|
-0.583 | - | - | $ 86.2 M | ||
|
Acorda Therapeutics
ACOR
|
-0.0662 | - | -24.86 % | $ 820 K | ||
|
Allakos
ALLK
|
-0.612 | - | - | $ 28.6 M | ||
|
Akebia Therapeutics
AKBA
|
-62.5 | $ 1.41 | -1.4 % | $ 363 M | ||
|
AlloVir
ALVR
|
-0.189 | - | 4.14 % | $ 49.1 M | ||
|
Applied Molecular Transport
AMTI
|
-0.175 | - | - | $ 10.1 M | ||
|
I-Mab
IMAB
|
-0.236 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
2.49 K | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Applied Therapeutics
APLT
|
-4.52 | - | - | $ 8.42 M | ||
|
Aravive
ARAV
|
-0.791 | - | -13.39 % | $ 1.45 M | ||
|
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
BioNTech SE
BNTX
|
6.11 | $ 91.98 | -0.11 % | $ 27.2 B | ||
|
Aytu BioScience
AYTU
|
-1.16 | $ 2.56 | -3.76 % | $ 16.1 M | ||
|
AstraZeneca PLC
AZN
|
706 | - | - | $ 96.9 B | ||
|
Alterity Therapeutics Limited
ATHE
|
-66.5 | $ 3.85 | -1.39 % | $ 9.26 B | ||
|
AVROBIO
AVRO
|
4.63 | - | 1083.1 % | $ 745 M | ||
|
Advaxis
ADXS
|
-0.0388 | - | -9.65 % | $ 45.9 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
12.7 | $ 20.87 | 2.3 % | $ 976 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.544 | - | -2.5 % | $ 5.88 M | ||
|
Aquestive Therapeutics
AQST
|
-5.58 | $ 4.17 | -0.24 % | $ 446 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
Arcutis Biotherapeutics
ARQT
|
-213 | $ 24.57 | -0.16 % | $ 3.13 B | ||
|
BeiGene, Ltd.
BGNE
|
-392 | - | 0.49 % | $ 251 B | ||
|
Aeterna Zentaris
AEZS
|
-4.94 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-0.00095 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-1.71 | - | - | $ 26.5 M | ||
|
CymaBay Therapeutics
CBAY
|
-32.5 | - | - | $ 3.45 B | ||
|
AIkido Pharma
AIKI
|
-1.33 | - | 1.93 % | $ 17.4 M | ||
|
Cabaletta Bio
CABA
|
-1.69 | $ 3.17 | 2.59 % | $ 319 M | ||
|
Codiak BioSciences
CDAK
|
-6.45 | - | -55.98 % | $ 2.15 M | ||
|
Aptose Biosciences
APTO
|
-0.0913 | - | -45.71 % | $ 1.2 M | ||
|
Avid Bioservices
CDMO
|
-3.01 | - | - | $ 789 M | ||
|
Cidara Therapeutics
CDTX
|
-0.873 | - | - | $ 1.41 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-400 | $ 2.93 | -4.87 % | $ 6.38 B | ||
|
Akero Therapeutics
AKRO
|
-12.9 | - | - | $ 3.67 B | ||
|
Checkpoint Therapeutics
CKPT
|
-2.85 | - | - | $ 169 M | ||
|
CureVac N.V.
CVAC
|
-8.58 | - | - | $ 867 M | ||
|
Celldex Therapeutics
CLDX
|
-7.88 | $ 33.62 | 3.73 % | $ 2.23 B | ||
|
Concert Pharmaceuticals
CNCE
|
-1.29 | - | - | $ 401 M | ||
|
Akari Therapeutics, Plc
AKTX
|
-467 | $ 3.92 | 1.03 % | $ 264 B | ||
|
Akouos
AKUS
|
-1.98 | - | 0.23 % | $ 488 M | ||
|
Celsion Corporation
CLSN
|
-0.108 | - | -6.63 % | $ 13.9 M | ||
|
Allena Pharmaceuticals
ALNA
|
-2.17 | - | 3.16 % | $ 1.9 M |